Global Awareness. Local Impact.
CLA's mission is to promote disease awareness, prevention, education, advocacy, and research. Headquartered in Pittsburgh, the Community Liver Alliance has grown to have a national presence while still holding true to a mission to invest in local communities and give voice to patients and providers.
Fresh-a-Fare
Jamison Lamb Farm 171 Jamison Lane, Latrobe, PA, United StatesSaturday, June 24, 2023 6:00-8:00 p.m. Jamison Lamb Farm 171 Jamison Ln Latrobe, PA 15650 $100 per ticket Tickets are limited to a max of 50 guests Register now! Fresh-a-Fare […]
Treating HCV in a Primary Care Setting
Virtual , United StatesHosted by Matthew Barnes, CRNP Crossroads Treatment Center Virtual via Zoom - Register now! *** Industry partners must have an exhibit or sponsorship to participate in the Community […]
HCV Provider Networking Meeting
Virtual , United StatesOpportunities to discuss what is new in the Hep C space with other professionals. Each meeting we will focus on one particular organization and their work, with a collaborative discussion […]
HCV Roundtable with the Expert
Virtual , United StatesPresented by Michael Babich, MD Allegheny Health Network Registration coming soon! *** Industry partners must have an exhibit or sponsorship to participate in the Community Liver Alliance programs and events. […]
Viral Hepatitis Summit (Pittsburgh, PA)
Cambria Hotel 1320 Centre Ave, Pittsburgh, PA, United StatesThe Community Liver Alliance in collaboration with the National Viral Hepatitis Roundtable, MidSouth Liver Alliance, Hep B Foundation, National Harm Reduction Coalition, Community Education Group, and other key stakeholders representing […]
Advocacy

2021 CLA Research Grant Awarded to Dr. Hamza Yazdani
Dr. Hamza Yazdani 2022 CLA Research Grant Recipient On behalf of the Community Liver Alliance and its Board of Directors, we are pleased to announce the winner of the 5th

Ask Congress to Support the LIVER Act
Ask Congress to Support the Liver Illness Visibility, Education, and Research (LIVER) Act What is the Liver Illness Visibility, Education, and Research (LIVER) Act?The LIVER Act is a public health
Advocacy
There is 80 to 100 million people in the USA that have Fatty Liver Disease and most do not even know they have it. Liver Disease does not discriminate. It affects any age, social economics and race. Liver cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time.
Ensure funding for COVID-19 and liver disease public health programs, research, vaccine dissemination; ensure that people living with liver disease are not disproportionately impacted and do not experience unnecessary or discriminatory health care or treatment disruptions.
Address inequities in the care of people impacted by liver disease, especially the excess incidence rate of liver cancer in black men in America.
Advance the U.S. NASH Action Plan, and ensure patients with liver disease perspectives are represented in relevant legislative packages: COVID-19, diabetes, and obesity.
Work with regulators to establish logical pathways to consistently approve therapies for liver diseases, particularly rare liver diseases.
Advocate for funding that ensures meaningful growth of vital liver disease research and the improving of liver health.
Urgently respond to the inequities that impact organ transplantation; modernize the U.S. Organ Donation system, improve care for transplant patients, and increase the number of available organs.
Increase support for hepatitis programs and raise awareness of viral hepatitis; advocate for the elimination of viral hepatitis .
Advance health care policies that reflect each person’s unique needs and drive access to personalized, patient-centric care.
Support policy solutions that curb patients’ health care expenses; advocate for the smoothing and capping of out-of-pocket costs in Medicare Part D.







